The United States awarded a $265 million contract to a Texas facility of Japan’s Fujifilm Holdings Corp to step up production of a coronavirus vaccine candidate, President Donald Trump said.
If you are not happy with the results below please do another search
50 search results for:
Moderna Inc. and Pfizer Inc. launched two 30,000-subject trials of Covid-19 vaccines that could clear the way for regulatory approval and widespread use by the end of 2020.
German biotech company BioNTech and U.S. drugmaker Pfizer said they would begin a pivotal global study to evaluate their lead COVID-19 vaccine candidate.
A meeting with top pharmaceutical executives that President Donald Trump promised wasn called off, a White House official said.
Coordinators of a global coronavirus vaccines funding scheme are looking at a wide range of potential prices for Covid-19 shots, with a reported $40 per dose price tag the “highest number” in that range, one of the co-leads of the project said.
AstraZeneca inked a global development and commercialization deal with Daiichi Sankyo for DS-1062, a trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate for multiple cancer types.
Moderna launched an expanded Phase III clinical trial of the mRNA-1273 Covid-19 vaccine and the Biomedical Advanced Research and Development Authority (BARDA) added additional funding for the clinical program.
Gaithersburg, Maryland-based Emergent BioSolutions inked another manufacturing agreement with AstraZeneca to support the development of a vaccine against Covid-19.
Covid-19 put many businesses on hold, but not biotech. This sector is growing at record speeds, and only a small portion of the capital deals are related to the pandemic.
European efforts to secure potential COVID-19 vaccines from Pfizer, Sanofi and Johnson & Johnson are mired in wrangles over price, payment method and potential liability costs, three EU officials told Reuters.